s6y

3 REGENERON PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001104659-16-144224

Documents

  1. 3 3
  2. EX-24.1 EX-24.1

On sec.gov